Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis

Abstract Background Locus coeruleus (LC) is a nucleus containing the cell bodies of noradrenergic neurons in the brain, and is one of the earliest regions affected by Alzheimer’s disease (AD). Norepinephrine (NE) is critical for cognitive functions as well as anti‐inflammatory and neuroprotective pr...

Full description

Bibliographic Details
Published in:Alzheimer's & Dementia
Main Authors: Iijima, Koichi M., Sakakibara, Yasufumi, Ibaraki, Kyoko, Takei, Kimi, Saito, Takashi, Saido, Takaomi C., Sekiya, Michiko
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2020
Subjects:
Online Access:http://dx.doi.org/10.1002/alz.044318
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.044318
id crwiley:10.1002/alz.044318
record_format openpolar
spelling crwiley:10.1002/alz.044318 2024-06-02T08:02:56+00:00 Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis Molecular and cell biology/APP/Abeta/amyloid Iijima, Koichi M. Sakakibara, Yasufumi Ibaraki, Kyoko Takei, Kimi Saito, Takashi Saido, Takaomi C. Sekiya, Michiko 2020 http://dx.doi.org/10.1002/alz.044318 https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.044318 en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor Alzheimer's & Dementia volume 16, issue S2 ISSN 1552-5260 1552-5279 journal-article 2020 crwiley https://doi.org/10.1002/alz.044318 2024-05-03T12:05:35Z Abstract Background Locus coeruleus (LC) is a nucleus containing the cell bodies of noradrenergic neurons in the brain, and is one of the earliest regions affected by Alzheimer’s disease (AD). Norepinephrine (NE) is critical for cognitive functions as well as anti‐inflammatory and neuroprotective properties, both of which are implicated in AD. LC neurons are among the first to display tau pathology and that significant loss of forebrain noradrenergic projections is evident at prodromal stage of AD, suggesting that abnormality in LC‐NE system initiates the disease pathogenesis. However, mechanisms underlying neurodegeneration in LC‐NE system remain elusive. We have previously reported that App NL‐G‐F/NL‐G‐F mice, which harbor three familial AD mutations (Swedish, Beyreuther/Iberian, and Arctic) exhibited cognitive deficits and severe neuroinflammation accompanied by massive amyloid‐β (Aβ) pathology. In this study, we asked whether and how LC‐NE system is altered in App NL‐G‐F/NL‐G‐F mice. Method To ask whether App NL‐G‐F/NL‐G‐F mice exhibit noradrenergic degeneration, we compared the density of norepinephrine transporter (NET)‐positive fibers in the cortex and hippocampus as well as the number of dopamine β‐hydroxylase (DBH)‐positive neurons in the LC between App NL‐G‐F/NL‐G‐F and wild‐type (WT) C57BL/6J mice at 24 months of age. We also examined whether tau pathology occurs in the LC‐NE system in these mice. Result Histochemical analyses revealed that 24‐month‐old App NL‐G‐F/NL‐G‐F mice exhibited significant decreases in the density of NET‐positive fibers in the prefrontal and entorhinal cortices and the hippocampal CA1, the regions associated with learning and memory, compared to WT mice. In contrast, App NL‐G‐F/NL‐G‐F mice did not display loss of DBH‐positive neurons in the LC even at 24 months of age. Furthermore, App NL‐G‐F/NL‐G‐F mice did not develop prominent tau pathology either in the nerve terminals or in the cell bodies of LC neurons. Conclusion This study demonstrates that Aβ pathology is sufficient ... Article in Journal/Newspaper Arctic Wiley Online Library Arctic Alzheimer's & Dementia 16 S2
institution Open Polar
collection Wiley Online Library
op_collection_id crwiley
language English
description Abstract Background Locus coeruleus (LC) is a nucleus containing the cell bodies of noradrenergic neurons in the brain, and is one of the earliest regions affected by Alzheimer’s disease (AD). Norepinephrine (NE) is critical for cognitive functions as well as anti‐inflammatory and neuroprotective properties, both of which are implicated in AD. LC neurons are among the first to display tau pathology and that significant loss of forebrain noradrenergic projections is evident at prodromal stage of AD, suggesting that abnormality in LC‐NE system initiates the disease pathogenesis. However, mechanisms underlying neurodegeneration in LC‐NE system remain elusive. We have previously reported that App NL‐G‐F/NL‐G‐F mice, which harbor three familial AD mutations (Swedish, Beyreuther/Iberian, and Arctic) exhibited cognitive deficits and severe neuroinflammation accompanied by massive amyloid‐β (Aβ) pathology. In this study, we asked whether and how LC‐NE system is altered in App NL‐G‐F/NL‐G‐F mice. Method To ask whether App NL‐G‐F/NL‐G‐F mice exhibit noradrenergic degeneration, we compared the density of norepinephrine transporter (NET)‐positive fibers in the cortex and hippocampus as well as the number of dopamine β‐hydroxylase (DBH)‐positive neurons in the LC between App NL‐G‐F/NL‐G‐F and wild‐type (WT) C57BL/6J mice at 24 months of age. We also examined whether tau pathology occurs in the LC‐NE system in these mice. Result Histochemical analyses revealed that 24‐month‐old App NL‐G‐F/NL‐G‐F mice exhibited significant decreases in the density of NET‐positive fibers in the prefrontal and entorhinal cortices and the hippocampal CA1, the regions associated with learning and memory, compared to WT mice. In contrast, App NL‐G‐F/NL‐G‐F mice did not display loss of DBH‐positive neurons in the LC even at 24 months of age. Furthermore, App NL‐G‐F/NL‐G‐F mice did not develop prominent tau pathology either in the nerve terminals or in the cell bodies of LC neurons. Conclusion This study demonstrates that Aβ pathology is sufficient ...
format Article in Journal/Newspaper
author Iijima, Koichi M.
Sakakibara, Yasufumi
Ibaraki, Kyoko
Takei, Kimi
Saito, Takashi
Saido, Takaomi C.
Sekiya, Michiko
spellingShingle Iijima, Koichi M.
Sakakibara, Yasufumi
Ibaraki, Kyoko
Takei, Kimi
Saito, Takashi
Saido, Takaomi C.
Sekiya, Michiko
Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis
author_facet Iijima, Koichi M.
Sakakibara, Yasufumi
Ibaraki, Kyoko
Takei, Kimi
Saito, Takashi
Saido, Takaomi C.
Sekiya, Michiko
author_sort Iijima, Koichi M.
title Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis
title_short Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis
title_full Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis
title_fullStr Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis
title_full_unstemmed Reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in APP knock‐in mouse models of Aβ amyloidosis
title_sort reduced density of noradrenergic fibers without prominent neuron loss or tau pathology in the locus coeruleus in app knock‐in mouse models of aβ amyloidosis
publisher Wiley
publishDate 2020
url http://dx.doi.org/10.1002/alz.044318
https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.044318
geographic Arctic
geographic_facet Arctic
genre Arctic
genre_facet Arctic
op_source Alzheimer's & Dementia
volume 16, issue S2
ISSN 1552-5260 1552-5279
op_rights http://onlinelibrary.wiley.com/termsAndConditions#vor
op_doi https://doi.org/10.1002/alz.044318
container_title Alzheimer's & Dementia
container_volume 16
container_issue S2
_version_ 1800747390800494592